Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.100
-0.020 (-0.94%)
At close: Sep 8, 2026, 4:00 PM EDT
2.100
0.00 (0.00%)
After-hours: Sep 8, 2026, 4:10 PM EDT
BDTX Market Cap
BDTX has a market cap or net worth of $120.65 million as of September 8, 2026. Its market cap has decreased by -27.92% in one year.
Market Cap
120.65M
Enterprise Value
27.12M
1-Year Change
-27.92%
Ranking
Category
Stock Price
$2.10
ChartMarket Cap Chart
Since January 30, 2020, BDTX's market cap has decreased from $1.36B to $120.65M, a decrease of -91.10%. That is a compound annual growth rate of -30.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 120.65M | -12.85% |
| Dec 31, 2025 | 138.45M | 14.33% |
| Dec 31, 2024 | 121.09M | -16.54% |
| Dec 29, 2023 | 145.09M | 121.66% |
| Dec 30, 2022 | 65.46M | -66.10% |
| Dec 31, 2021 | 193.10M | -83.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Conexeu Sciences | 132.99M |
| Tiziana Life Sciences | 131.89M |
| NeOnc Technologies Holdings | 125.03M |
| enGene Therapeutics | 121.92M |
| Cibus | 121.52M |
| Rani Therapeutics Holdings | 120.62M |
| Aardvark Therapeutics | 117.74M |
| Connect Biopharma Holdings | 115.87M |